Experimental study of MRP1 gene expression of adenovirus-mediated hairpin RNA inhibition of arsenic trioxide resistant K562/AS2 cell line
- Author:
- No author available
- Journal Title:
- JOURNAL OF LEUKEMIA & LYMPHOMA
- Issue:
- 5
- DOI:
- 10.3760/cma.j.issn.1009-9921.2010.05.007
- Key Word:
- 肿瘤,实验性;腺病毒载体;RNA;砷剂;抗药性,肿瘤;基因,MRP1;K562细胞;Neoplasms,experimental;Adenovirus vector;RNA;Arsenicals;Drug resistance,neoplasm;Genes,MRP1;K562 cells
Abstract： Objective To construct a recombinant adenovirus vector of Hairpin RNA specific for MRP1 gene and study its inhibition of MRP1 gene expression in K562/AS2 cell line resistant to AS_2O_3 (ATO). Methods A MRP1-specific hairpin RNA recombinant adenovirus vector was constructed and used to infected K562/AS2 cells. Expression level of MRP1 mRNA detected by real-time fluorescent quantitative PCR. MRP1 protein detected by flow cytometry. MTT method was used to detected the cytotoxicity of ATO and etoposide. Results MRP1 mRNA and protein expression level in K562/AS2 cells before and after the pAd-MRPl-shRNA adenovirus infection was (34.70±0.28 vs 4.19±0.03, P <0.05) and (26.40±0.16 vs 10.85±0.37, P<0.05), respectively. RR of K562/AS2 to arsenic trioxide and etoposide was (11.4078±0.3183 fold vs 1.6126±0.3015 fold, P<0.05) and (5.9141 ±0.0149 fold vs 1.7664±0.1038 fold, P <0.05), respectively. The reversal fold of ATO and etoposide was (7.2409±1.3668) and (3.3555±0.1886), respectively. Conclusion Successfully constructed pAd-EGFP-U6-shRNA-MRPl adenovirus vector, the vector of infection K562/SA2 cells can inhibit MRP1 gene expression and reverse the resistance of the ATO and etoposide.
- [1]赵文增,刘荣红,谢荣辉,等.MRP1在大肠癌中表达的研究[J].2008,(4).
- [2]田长富,刘旭,李殿俊.癌基因治疗中的腺病毒载体的开发和应用（综述Ⅰ）[J].2000,(1).
- [3]周庚寅,张晓芳.肿瘤多药耐药机制及其逆转[J].2009,(4).
- [4]任亚娟,田雪红,糜若然.MRPl在上皮性卵巢癌中的表达及临床意义[J].2008,(2).
- [5]卓家才,游伟文,蔡力生,等.K562/AS2细胞株对三氧化二砷耐药机制的初步研究[J].2008,(10).
- [6]苏晓星,卓家才,古庆利,等.短发夹RNA抑制三氧化二砷耐药的白血病K562/AS2细胞MRPI基因表达的实验研究[J].2009,(7).
- [7]张群,陈龙邦,臧静,等.乳腺癌患者尿液基质金属蛋白酶检测的临床意义[J].2003,(8).
- [8]卓家才,汪明春,陶小梅,等.三氧化二砷耐药白血病细胞株K562/AS2的建立及其与多药耐药的关系[J].2002,(7).
- [9]Lorico A,Finch RA,Sartorelli AC,etc.New insights into the biology and pharmacology of the multidrug resistance protein (MRP) from gene knockout models.[J].1999,58(4).
- [10]Bosch A,Alba R,Chillon M.Gutless adenovirus: last-generation adenovirus for gene therapy.[J].2005,12(Suppl.1).
- [11]Zhou GY,Li WT,Wang XW,etc.Modulation of BCRP mediated atypical multidrug resistance phenotype by RNA interference.[J].2005,52(3).
- [12]主编查锡良.医学分子生物学[M].2003.
- [13]Sun YL,Bai YH,Zhou GY,etc.Suppression of glucosylceramide synthase by RNA interference reverses multidrug resistance in human breast cancer cells.[J].2006,53(1).
- [14]Hans Prydz,Merete T. Wiiger,Mohammed Amarzguioui,etc.Positional effects of short interfering RNAs targeting the human coagulation trigger Tissue Factor[J].2002,30(8).
- [15]Cole, S.P.C.,Bhardwaj, G..Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line.[J].1992,258(5088).
- [16]周新,涂植光.临床生物化学和生物化学检验[M].1900.